0      0

29th Annual North American Cystic Fibrosis Conference

W17: CLIN: Gastroenterology/Liver/Pancreas

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

Standard: $49.99


A focused discussion of emerging evidence for improving care and clinical outcomes in adult and pediatric patients with gastrointestinal/hepatic/pancreatic (GI) sequelae of Cystic Fibrosis (CF), particularly regarding concerted treatment and screening initiatives that will come into play for more CF patients with progressively rising life expectancy outcomes.

Educational Objectives: 

  1. Evaluate available screening strategies for evolving CF GI diseases.
  2. Discuss how structured Quality Improvement processes can strengthen the patient/provider partnership in CF Nutrition.
  3. Examine strategies to optimize pancreatic enzyme supplementation and efficacy in CF patients.
  4. Consider potential biomarkers and therapeutic pathways for future treatment of CF GI diseases. 


You must be logged in and own this session in order to post comments.